James C Sacco1, Lauren A Trepanier. 1. Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Abstract
OBJECTIVES: NADH cytochrome b5 reductase (b5R) and cytochrome b5 (b5) catalyze the reduction of sulfamethoxazole hydroxylamine (SMX-HA), which can contribute to sulfonamide hypersensitivity, to the parent drug sulfamethoxazole. Variability in hydroxylamine reduction could thus play a role in adverse drug reactions. The aim of this study was to characterize variability in SMX-HA reduction in 111 human livers, and investigate its association with single nucleotide polymorphisms (SNPs) in b5 and b5R cDNA. METHODS: Liver microsomes were assayed for SMX-HA reduction activity, and b5 and b5R expression was semiquantified by immunoblotting. The coding regions of the b5 (CYB5A) and b5R (CYB5R3) genes were resequenced. RESULTS: Hepatic SMX-HA reduction displayed a 19-fold range of individual variability (0.06-1.11 nmol/min/mg protein), and a 17-fold range in efficiency (Vmax/Km) among outliers. SMX-HA reduction was positively correlated with b5 and b5R protein content (P<0.0001, r=0.42; P=0.01, r=0.23, respectively), and expression of both proteins correlated with one another (P<0.0001; r=0.74). A novel cSNP in CYB5A (S5A) was associated with very low activity and protein expression. Two novel CYB5R3 SNPs, R59H and R297H, displayed atypical SMX-HA reduction kinetics and decreased SMX-HA reduction efficiency. CONCLUSION: These studies indicate that although novel cSNPs in CYB5A and CYB5R3 are associated with significantly altered protein expression and/or hydroxylamine reduction activities, these low-frequency cSNPs seem to only minimally impact overall observed phenotypic variability. Work is underway to characterize polymorphisms in other regions of these genes to further account for individual variability in hydroxylamine reduction.
OBJECTIVES:NADHcytochrome b5 reductase (b5R) and cytochrome b5 (b5) catalyze the reduction of sulfamethoxazole hydroxylamine (SMX-HA), which can contribute to sulfonamidehypersensitivity, to the parent drug sulfamethoxazole. Variability in hydroxylamine reduction could thus play a role in adverse drug reactions. The aim of this study was to characterize variability in SMX-HA reduction in 111 human livers, and investigate its association with single nucleotide polymorphisms (SNPs) in b5 and b5R cDNA. METHODS: Liver microsomes were assayed for SMX-HA reduction activity, and b5 and b5R expression was semiquantified by immunoblotting. The coding regions of the b5 (CYB5A) and b5R (CYB5R3) genes were resequenced. RESULTS: Hepatic SMX-HA reduction displayed a 19-fold range of individual variability (0.06-1.11 nmol/min/mg protein), and a 17-fold range in efficiency (Vmax/Km) among outliers. SMX-HA reduction was positively correlated with b5 and b5R protein content (P<0.0001, r=0.42; P=0.01, r=0.23, respectively), and expression of both proteins correlated with one another (P<0.0001; r=0.74). A novel cSNP in CYB5A (S5A) was associated with very low activity and protein expression. Two novel CYB5R3 SNPs, R59H and R297H, displayed atypical SMX-HA reduction kinetics and decreased SMX-HA reduction efficiency. CONCLUSION: These studies indicate that although novel cSNPs in CYB5A and CYB5R3 are associated with significantly altered protein expression and/or hydroxylamine reduction activities, these low-frequency cSNPs seem to only minimally impact overall observed phenotypic variability. Work is underway to characterize polymorphisms in other regions of these genes to further account for individual variability in hydroxylamine reduction.
Authors: Linling Cheng; Benjamin J Stewart; Qiang You; Dennis R Petersen; Joseph A Ware; Joseph R Piccotti; Thomas T Kawabata; Cynthia Ju Journal: Mol Pharmacol Date: 2008-03-11 Impact factor: 4.436
Authors: Melanie J Percy; Matthew J S Gillespie; Geraldine Savage; Anne E Hughes; Mary Frances McMullin; Terry R J Lappin Journal: Blood Date: 2002-07-05 Impact factor: 22.113
Authors: Emilio Siendones; Sara SantaCruz-Calvo; Alejandro Martín-Montalvo; María V Cascajo; Julia Ariza; Guillermo López-Lluch; José M Villalba; Cécile Acquaviva-Bourdain; Emmanuel Roze; Michel Bernier; Rafael de Cabo; Plácido Navas Journal: Antioxid Redox Signal Date: 2014-02-28 Impact factor: 8.401
Authors: Md Mizanur Rahaman; Fabio G Reinders; David Koes; Anh T Nguyen; Stephanie M Mutchler; Courtney Sparacino-Watkins; Roger A Alvarez; Megan P Miller; Dongmei Cheng; Bill B Chen; Edwin K Jackson; Carlos J Camacho; Adam C Straub Journal: J Biol Chem Date: 2015-05-22 Impact factor: 5.157
Authors: J Funk-Keenan; J Sacco; Y Y Amos Wong; S Rasmussen; A Motsinger-Reif; L A Trepanier Journal: J Vet Intern Med Date: 2012-07-21 Impact factor: 3.333
Authors: Brittany G Durgin; Scott A Hahn; Heidi M Schmidt; Megan P Miller; Neha Hafeez; Ilka Mathar; Daniel Freitag; Peter Sandner; Adam C Straub Journal: JCI Insight Date: 2019-10-03
Authors: Ayman Elsheikh; Sidonie N Lavergne; J Luis Castrejon; John Farrell; Haiyi Wang; Jean Sathish; Werner J Pichler; B Kevin Park; Dean J Naisbitt Journal: J Immunol Date: 2010-10-27 Impact factor: 5.422
Authors: Mizanur M Rahaman; Anh T Nguyen; Megan P Miller; Scott A Hahn; Courtney Sparacino-Watkins; Soma Jobbagy; Nolan T Carew; Nadiezhda Cantu-Medellin; Katherine C Wood; Catherine J Baty; Francisco J Schopfer; Eric E Kelley; Mark T Gladwin; Emil Martin; Adam C Straub Journal: Circ Res Date: 2017-06-05 Impact factor: 17.367
Authors: Kristina L Blanke; James C Sacco; Robert C Millikan; Andrew F Olshan; Jingchun Luo; Lauren A Trepanier Journal: Cancer Causes Control Date: 2014-09-16 Impact factor: 2.506
Authors: Jonine D Figueroa; Summer S Han; Montserrat Garcia-Closas; Dalsu Baris; Eric J Jacobs; Manolis Kogevinas; Molly Schwenn; Nuria Malats; Alison Johnson; Mark P Purdue; Neil Caporaso; Maria Teresa Landi; Ludmila Prokunina-Olsson; Zhaoming Wang; Amy Hutchinson; Laurie Burdette; William Wheeler; Paolo Vineis; Afshan Siddiq; Victoria K Cortessis; Charles Kooperberg; Olivier Cussenot; Simone Benhamou; Jennifer Prescott; Stefano Porru; H Bas Bueno-de-Mesquita; Dimitrios Trichopoulos; Börje Ljungberg; Françoise Clavel-Chapelon; Elisabete Weiderpass; Vittorio Krogh; Miren Dorronsoro; Ruth Travis; Anne Tjønneland; Paul Brenan; Jenny Chang-Claude; Elio Riboli; David Conti; Manuela Gago-Dominguez; Mariana C Stern; Malcolm C Pike; David Van Den Berg; Jian-Min Yuan; Chancellor Hohensee; Rebecca Rodabough; Geraldine Cancel-Tassin; Morgan Roupret; Eva Comperat; Constance Chen; Immaculata De Vivo; Edward Giovannucci; David J Hunter; Peter Kraft; Sara Lindstrom; Angela Carta; Sofia Pavanello; Cecilia Arici; Giuseppe Mastrangelo; Margaret R Karagas; Alan Schned; Karla R Armenti; G M Monawar Hosain; Chris A Haiman; Joseph F Fraumeni; Stephen J Chanock; Nilanjan Chatterjee; Nathaniel Rothman; Debra T Silverman Journal: Carcinogenesis Date: 2014-03-24 Impact factor: 4.944